One month to go! We’re delighted to introduce our amazing speakers who are looking forward to sharing their knowledge and expertise with you in a more intimate setting. Secure your spot today 👉 https://t.co/2NvgwOCGuT

The program is shaping up fast! We’re building in plenty of space for audience participation, live Q&A and open discussion, so you’ll have the chance to share your views and connect directly with experts. Don’t just attend—be part of the conversation! https://t.co/QJBZS9d3tt

Join us for our collaborative event with @USANZUrology as we explore the latest clinical trials management and research developments across Below the Belt cancers. Places are limited—secure your spot today and stay at the forefront of research! https://t.co/QJBZS9d3tt

@zklaassen_md @urotoday @RKSayyid @chavarriagaj Also first results from #ENZARAD #ProstateCancer #pcsm #ClinicalTrial as an oral late-breaking presentation by @DrPaulNguyen - don’t miss it. #ESMO25 @ANZUPtrials @TrialsCentre @DanaFarber_GU @cancertrials_ie @EORTC

Registrations now open! https://t.co/fFA9hGVRMf Following the outstanding success of the 2024 Preceptorship, which welcomed over 360 delegates from 26 countries and featured expert speakers from five continents, we are excited to invite you to our ProsTIC Preceptorship 2026.

The Best of GU Evening Symposium is a collaboration between @ANZUPTrials and @USANZUrology – featuring highlights from the #ANZUP25 ASM, #GU25, #ASCO25, #ESMO25 and UAA Congress 2025. Spaces are limited so register now! @Prof_IanD https://t.co/QJBZS9dBj1

First @ANZUPtrials Ideas Generation Workshop in New Zealand - putting the NZ into ANZUP! Thanks to @nickymitchell and @DrCraigGedye for the warm welcome.

Researchers & health pros: Have you worked with CALD communities in Australia using patient-reported outcomes (PROs)? Share your insights in a 20-min anonymous survey by Sept 10! 🔗 https://t.co/Cg6KS1OZdD or 📧 health-outcomes.ctc@sydney.edu.au #CALD #PROs #HealthResearch

Associate Professor Andrew Weickhardt recently covered the @ANZUPtrials ASM 2025 in this Conference Review ➡️ https://t.co/mjLAOzBgB1

The 4th Asia Pacific Advanced Prostate Cancer Consensus Meeting: How much has changed? Many questions answered, yet so many known unknowns remain. @ANZUPtrials @USANZUrology @BJUIjournal @bjuiknowledge @Uroweb

That’s a wrap of the @ANZUPTrials #APCCC APAC Satellite Conference. Many thanks to Convenors @Prof_IanD @RenuEapen @EdChiongUROonc & @declangmurphy. Also thanks to our sponsors - Gold: @Bayer @JNJNews @Novartis, Supporters: @AstellasUS @Pfizer #APCCCinAPAC25 #ProstateCancer

We're excited to be joined today by close to 30 clinical experts from 14 countries to review & test 5 key themes from #APCCC24 from an APAC perspective @ANZUPTrials #ProstateCancer consensus meeting #APCCCinAPAC25 @Prof_IanD @RenuEapen @EdChiongUROonc @declangmurphy

Presented at the ANZUP RCC IGW in Sydney. Grateful for the opportunity to share an idea aimed at improving RCC care. Excited about the potential for future collaboration. @ANZUPtrials @MyUrologyAssoc @UiTMMedic @MonashHealth @USANZUrology

Congratulations! @ANZUPTrials #WOMBAT Phase 2 #ProstateCancer study has reached 20% recruitment. Well done to all involved @AnthonyMJoshua #MeganCrumbaker @georgeinstitute @Bayer @Prof_IanD @PCFA #ProstateCancerAustralia @CancerAustralia

Just 2 weeks ago during @ANZUPtrials Annual Meeting, I had called out this phenomenon of “in mice”. My interview with @doccharris and @DrL_Krieger is now available to watch-

During @ANZUPtrials #ANZUP25 I chatted with Dr Natasha Roberts about a recent paper she has had published reporting experiences of participants in #ClinicalTrials. You can listen to interview & find the paper here: https://t.co/hLX4mGSNva https://t.co/xHaBwILaeP via @YouTube

For the first time @ANZUPtrials had a session dedicated to #ClinicalTrial Coordinators, it covered running theranostics trials, #PROs, & #TeleTrials I had a chat with session coordinator Brandan Holt https://t.co/H8HCHn2oSx via @YouTube

🚨Online today: Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant #prostatecancer in #ENZAp (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trial https://t.co/BPejpkHvgb

Third @LancetOncology paper to come out of the @ANZUPtrials #ENZAp #ProstateCancer #pcsm #ClinicalTrial - congratulations Louise Emmett and grateful thanks to all investigators, research teams, and of course the participants who have helped move the whole field ahead.

Congratulations @ANZUPtrials #ENZAp @TheLancetOncol publication by @drlouiseemmett & the entire team @MovemberAUS @CancerAustralia @AstellasEurope #ARTnet @StVincentClinic @RoyMorganAus @Novartis @mimsoftware @GenesisCare @ANSTO @TrialsCentre @Prof_IanD